Switch to:
More From Other Websites
10-K for CEL-SCI Corp. Dec 25 2014
CEL SCI CORP Files SEC form 10-K, Annual Report Dec 23 2014
CEL-SCI Reports Fiscal 2014 Financial Results and Clinical & Corporate Developments Dec 23 2014
NEW STORY CEL-SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck Cancer Trial with... Dec 08 2014
CEL-SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck Cancer Trial With Addition of 7... Dec 08 2014
NEW STORY CEL-SCI Quarterly Patient Enrollment in Its Head and Neck Cancer Phase III Trial Increases... Dec 02 2014
CEL-SCI Quarterly Patient Enrollment in Its Head and Neck Cancer Phase III Trial Increases Eight... Dec 02 2014
NEW STORY CEL-SCI Enrolls 22 Patients during October in Its Phase III Immunotherapy Head and Neck... Nov 03 2014
CEL-SCI Enrolls 22 Patients During October in Its Phase III Immunotherapy Head and Neck Cancer Trial Nov 03 2014
NEW STORY CEL-SCI Corporation Announces Closing of Public Offering for Gross Proceeds of $6 Million Nov 02 2014
CEL-SCI Corporation Announces Closing of Public Offering for Gross Proceeds of $6 Million Oct 24 2014
CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... Oct 23 2014
CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... Oct 22 2014
NEW STORY CEL-SCI Corporation Prices $6 Million Public Offering of Common Stock and Warrants Oct 21 2014
NEW STORY CEL-SCI Corporation to Raise $1 Million in Registered Direct Offering Oct 21 2014
CEL-SCI Corporation to Raise $1 Million in Registered Direct Offering Oct 21 2014
CEL-SCI Corporation Prices $6 Million Public Offering of Common Stock and Warrants Oct 21 2014
NEW STORY CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants Oct 20 2014
CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants Oct 20 2014
CEL-SCI Enrolls 16 Patients in September in Its Phase III Immunotherapy Head and Neck Cancer Trial Oct 03 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK